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Brain gliomas: Comparison between the human and canine
species
Introduction and objectives
Primary neoplasms of the brain are relatively common in dogs and humans (14,5 per 100,000
pets at risk vs 20,5 per 100,000 patients at risk, respectively). As there are demonstrated
similarities between human and canine gliomas the objective of this study is to review the
current literature about diagnostic tools, treatments, staging methods, prognosis and sequels for
both species.
Classification of gliomas
Diffuse astrocytoma (grade II astrocytoma) Glioblastoma multiforme (grade IV astrocytoma)
Oligodendroglioma Mixed glioma (Oligoastrocytoma)
Ependymoma Gliomatosis cerebri
Conclusions
Human vs Canine
Diagnosis
Based on MRI. Similar clinical findings 
and symptoms. Gene mutation studies 
included to have more information.
Based on MRI. Similar clinical findings 
and symptoms. No gene mutations 
identified.
Staging
2016 WHO classification of tumors 
based on histological, genetical and 
molecular characteristics
2007 WHO classification of tumors 
based only on histological 
characteristics
Treatment
Surgery and RT as base, plus 
chemotherapy. Experimental 
treatments such as CED and VMAT
Surgery and RT as base, chemotherapy 
does not increase survival rates. 
Experimental treatments such as SRS 
and IT
Prognosis
Highly variable, depends on entity, 
grade of tumor, age, mental and 
physical status and treatment
Poor prognosis and/or euthanasia. At 
most 2 years of median survival time
Sequels
Caused by tumor location, size and 
grade and treatment applied.
Observable sequels are basically due to 
treatment (euthanized or death before 
the disease advances).
